sb 203580 has been researched along with stattic in 1 studies
Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (stattic) | Trials (stattic) | Recent Studies (post-2010) (stattic) |
---|---|---|---|---|---|
3,489 | 4 | 1,137 | 142 | 0 | 130 |
Protein | Taxonomy | sb 203580 (IC50) | stattic (IC50) |
---|---|---|---|
Signal transducer and activator of transcription 3 | Homo sapiens (human) | 5.1 | |
Hypoxia-inducible factor 1-alpha | Homo sapiens (human) | 0.043 | |
Thioredoxin glutathione reductase | Schistosoma mansoni | 2.01 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bartsch, S; Klettner, A; Lassen, J; Roider, J; Westhues, D | 1 |
1 other study(ies) available for sb 203580 and stattic
Article | Year |
---|---|
Regulation of constitutive vascular endothelial growth factor secretion in retinal pigment epithelium/choroid organ cultures: p38, nuclear factor κB, and the vascular endothelial growth factor receptor-2/phosphatidylinositol 3 kinase pathway.
Topics: Animals; Choroid; Chromones; Cinnamates; Cyclic S-Oxides; Imidazoles; Indazoles; Indoles; Maleimides; MAP Kinase Signaling System; Morpholines; NF-kappa B; Organ Culture Techniques; p38 Mitogen-Activated Protein Kinases; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Plicamycin; Pyridines; Retinal Pigment Epithelium; Signal Transduction; Sus scrofa; Transcription Factors; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2 | 2013 |